News Overview

PTW has entered into a distribution agreement with DE.TEC.TOR, a Turin-based developer and manufacturer of high-precision quality assurance (QA) devices for particle therapy.

[German Language] Vom Bundesministerium für Wirtschaft und Klimaschutz gefördertes PTW-Entwicklungsprojekt "Präzise Dosimetrie bei MR-geführter Strahlentherapie" als „ZIM (Zentrales Innovationsprogramm Mittelstand) -Erfolgsbeispiel“ ausgewählt

With the award PTW honours scientific commitment in the field of medical physics. The 2022 prize went to a PhD student from Heidelberg.

Learn more about the experts in the development of imaging and therapy phantoms made of soft tissue-, bone- and water-equivalent materials, solid resins, or PMMA.

The dosimetry specialist PTW Freiburg GmbH (PTW) will serve customers in Norway directly through its branch office PTW Benelux to better address the growing needs of the Norwegian radiotherapy market. Operations will officially start on September 1, 2022.

[German language] Wie schafft es ein Unternehmen, 100 Jahre zu werden?

100 Years of Inventive Spirit at PTW: From Hammer Dosemeter to Today and Beyond

PTW has received approval from U.S. Food and Drug Administration (FDA) of its integrated software platform VERIQA for automated patient plan verification in radiotherapy QA.

PTW Netherlands will assume the exclusive distribution rights for PTW products in Belgium and Luxembourg effective March 1, 2022. As a result, PTW Netherlands will change its name to PTW Benelux.